Sophrosyne Capital’s Nektar Therapeutics NKTR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-4,013	Closed	-$728K	–	73
2014 Q1	$728K	Buy	+4,013	New	+$728K	0.64%	33
2013 Q4	–	Sell	-9,140	Closed	-$1.43M	–	73
2013 Q3	$1.43M	Buy	+9,140	New	+$1.43M	0.95%	30